EP2366393
Roflumilast til meðhöndlunar á lungna háþrýstingi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.4.2006EP published:
7.8.2013EP application number:
11168764.6
EP translation filed:
27.11.2013Grant published:
15.12.2013EPO information:
European Patent Register
Max expiry date:
11.4.2026Expiry date:
11.4.2016
Title:
Roflumilast for the treatment of pulmonary hypertension
Timeline
Today
12.4.2006EP application
7.8.2013EP Publication
27.11.2013Translation submitted
15.12.2013Registration published
11.4.2016Expires
Owner
Name:
Takeda GmbHAddress:
Byk-Gulden-Strasse 2, 78467, Konstanz, DE
Inventor
Name:
Beume, RolfAddress:
Konstanz, DE
Name:
Hatzelmann, ArminAddress:
Konstanz, DE
Name:
Marx, DegenhardAddress:
Moos, DE
Name:
Schudt, ChristianAddress:
Konstanz, DE
Name:
Tenor, HermannAddress:
Konstanz, DE
Name:
Eddahibi, SaadiaAddress:
Fontenay-aux-Roses, FR
Name:
Adnot, SergeAddress:
Saint Maur des Fossés, FR
Agent
Name:
Reynaldsson Patent ConsultingAddress:
Pósthólf 48, 212, Garðabæ,
Priority
Number:
05103147Date:
19.4.2005Country:
EP
Classification
Categories:
A61K 31/44, A61K 31/4412, A61K 31/4985, A61K 31/5025, A61K 31/506, A61K 31/519, A61K 31/53, A61P 9/12
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 6.3.2014
Expires: 11.4.2015
Payer: Árnason Faktor
Number: 10
Paid: 9.3.2015
Expires: 11.4.2016
Payer: Árnason Faktor